The Journal of Clinical Endocrinology & Metabolism · 1996 · 48 citations · 9 references
Life SciencesGeneticsMolecular GeneticsCancer GeneticsMedical GeneticsNeoplasiaAdrenal Disorder GeneticsAdrenal TumorsGenetic DisordersHereditary Cancer SyndromesPediatric TumorsClinical Genetic DiagnosisFamilial ParagangliomaHereditary PheochromocytomaMutationPheochromocytoma GeneticsVhl Gene AlterationsVon Hippel-lindau DiseaseVon Hippel-lindau Syndrome
We report a three generation, 25 member kindred with familial pheochromocytoma. Seven subjects of generations I and II had pheochromocytoma, in five of the seven, the tumors were bilateral, and in two of the seven, the tumors were both adrenal and extraadrenal. One patient also had a carotid body chemodectoma, and one patient had a malignant adrenal tumor and abdominal paraganglioma. In the patient with the chemodectoma, a cerebellar hemangioblastoma became manifest 25 yr after his initial diagnosis with pheochromocytoma, leading only then to a clinical diagnosis of von Hippel-Lindau disease (VHL). A mutational analysis of the VHL gene revealed a novel nucleotide 709 G-->T transversion present in all affected subjects and in four presymptomatic children. In familial pheochromocytoma the diagnosis of VHL should be considered, even when the formal criteria for diagnosis of the syndrome are lacking.
9
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Farida Latif, Kálmán Tory, James R. Gnarra et al. · Science · 1993 · 3K citations
Kenneth L. Melmon, Saul W. Rosen · The American Journal of Medicine · 1964 · 612 citations
Pheochromocytoma as the first manifestation of von Hippel-Lindau disease.
J M Duclos, J.P. Fendler, Henri Plauchu et al. · PubMed · 1994 · 85 citations
Medicine, Endocrinology, Pathology +10